Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Bladder carcinoma in situ (CIS) in Australia: a rising incidence for an under-reported malignancy.

Ranasinghe WK, Attia J, Oldmeadow C, Lawrentschuk N, Robertson J, Ranasinghe T, Bolton D, Persad R.

BJU Int. 2013 Nov;112 Suppl 2:46-52. doi: 10.1111/bju.12052.

2.

Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985-2003.

Copeland G, Datta SD, Spivak G, Garvin AD, Cote ML.

Cancer. 2008 Nov 15;113(10 Suppl):2946-54. doi: 10.1002/cncr.23747.

3.

Clinical outcomes of bacillus Calmette-Guérin instillation therapy for carcinoma in situ of urinary bladder.

Takenaka A, Yamada Y, Miyake H, Hara I, Fujisawa M.

Int J Urol. 2008 Apr;15(4):309-13. doi: 10.1111/j.1442-2042.2008.02012.x.

4.

Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy.

Lodde M, Mayr R, Martini T, Comploj E, Palermo S, Trenti E, Hanspeter E, Fritsche HM, Mian C, Pycha A.

World J Urol. 2012 Dec;30(6):841-6. doi: 10.1007/s00345-012-0975-1.

PMID:
23143733
5.

Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.

Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I.

Cancer Causes Control. 2006 Feb;17(1):21-7.

PMID:
16411049
6.

Risk of concomitant carcinoma in situ determining biopsy candidates among primary non-muscle-invasive bladder cancer patients: retrospective analysis of 173 Japanese cases.

Hara T, Takahashi M, Gondo T, Nagao K, Ohmi C, Sakano S, Naito K, Matsuyama H.

Int J Urol. 2009 Mar;16(3):293-8. doi: 10.1111/j.1442-2042.2008.02241.x.

7.

Cancer in Australia: Actual incidence data from 1991 to 2009 and mortality data from 1991 to 2010 with projections to 2012.

Australian Institute of Health and Welfare..

Asia Pac J Clin Oncol. 2013 Sep;9(3):199-213. doi: 10.1111/ajco.12127.

PMID:
23961960
8.

Carcinoma in situ of urinary bladder: incidence, treatment and clinical outcomes during ten-year follow-up.

Librenjak D, Novaković ZS, Milostić K.

Acta Clin Croat. 2012 Jun;51(2):201-7.

PMID:
23115943
9.

A comprehensive evaluation of bladder cancer epidemiology and outcomes in Australia.

Cheluvappa R, Smith DP, Cerimagic S, Patel MI.

Int Urol Nephrol. 2014 Jul;46(7):1351-60. doi: 10.1007/s11255-014-0643-z.

PMID:
24488686
10.

Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.

Palou J, Sylvester RJ, Faba OR, Parada R, Peña JA, Algaba F, Villavicencio H.

Eur Urol. 2012 Jul;62(1):118-25. doi: 10.1016/j.eururo.2011.10.029.

PMID:
22101115
11.

Clinical evaluation of random biopsy of urinary bladder in patients with superficial bladder cancer.

Taguchi I, Gohji K, Hara I, Gotoh A, Yamada Y, Yamanaka K, Okada H, Arakawa S, Kamidono S.

Int J Urol. 1998 Jan;5(1):30-4.

12.
13.

Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies.

Hermann GG, Mogensen K, Toft BG, Glenthøj A, Pedersen HM.

Scand J Urol Nephrol. 2012 Feb;46(1):31-6. doi: 10.3109/00365599.2011.637954.

PMID:
22150596
14.
15.

Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery.

Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB.

J Urol. 2004 Feb;171(2 Pt 1):646-51.

PMID:
14713778
16.

Diagnosing the location of carcinoma in situ (CIS) of the urinary bladder using pirarubicin hydrochloride.

Uchikoba T, Horiuchi K, Oka F, Sato M, Tsuboi N, Ohaki Y, Nishimura T.

Urol Int. 2005;74(3):235-9.

PMID:
15812210
17.

[Localization diagnosis of carcinoma in situ of bladder cancer by pirarubicin: preliminary clinical experience].

Xia SJ, Liu HT, Ruan Y, Xue S, Zhang J, Sun XW, Han BM, Zhu YY, Zhuo J.

Zhonghua Yi Xue Za Zhi. 2010 May 11;90(18):1239-42. Chinese.

PMID:
20646594
18.
20.

Diagnosis, evaluation and treatment of carcinoma in situ of the urinary bladder: the state of the art.

Williamson SR, Montironi R, Lopez-Beltran A, MacLennan GT, Davidson DD, Cheng L.

Crit Rev Oncol Hematol. 2010 Nov;76(2):112-26. doi: 10.1016/j.critrevonc.2010.01.005. Review.

PMID:
20097572
Items per page

Supplemental Content

Support Center